DiaMedica Therapeutics Inc.
-
Ticker
DMAC
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1-10 Employees
- Based in Minneapolis, Minnesota
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for neurological and kidney diseases. DiaMedica’s common shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.”
DiaMedica Therapeutics Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports